Cerebral Micro Emboli Signal Detection in Endocarditis. A prospective follow-up study

Cerebral Micro Emboli Signal Detection in Endocarditis. A prospective follow-up study - CMED

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON54754

Enrollment

100

Registered

2018-09-11

Start date

2019-02-15

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endocarditis micro embolie detectie ontsteking van het weefsel van de hartkamer

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Proven left-tailed infective native endocarditis or bioprosthetic valves endocarditis 2. ultrasound test of the heart not older than 2 weeks 3. 18 years and older 4. mentally competent 5. written informed consent

Exclusion criteria

Exclusion criteria: 1. right-tailed endocarditis 2. left-tailed endocarditis with already an emergency indication for heartsurgery/valve replacement (

Design outcomes

Primary

Measure	Time frame
Primary endpoint: development of a CVA during the hospitalization	—

Secondary

Measure	Time frame
Secondary neurological endpoints are: 1. The severity of the CVA at origin and after 3 months (NIHSS score), the type of CVA (ischemic or hemorrhage) 2. Occurrence of TIA's, 3. Occurrence of meningitis, 4. developing a cerebral abscess/cerebritis, 5. mortality, 6. functional outcome after 3 months 7. SWI/DWI/Flair and T2 lesions on MRI brain (after 3 months or	—

Countries

Netherlands

Outcome results